James E Brown

USPTO Granted Patents = 12 (Patent Applications = 12)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 1,189(Granted Patents)

Company Filing History:

Virginia Commonwealth University

patents

where one patent can have more than one assignee

Years Active: 1999-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11612609 - Uses of oxygenated cholesterol sulfates (OCS) (2023-03-28),

2. 10786517 - Uses of oxygenated cholesterol sulfates (OCS) (2020-09-29),

3. 10272097 - Uses of oxygenated cholesterol sulfates (OCS) (2019-04-30),

4. 8956644 - Transdermal delivery systems (2015-02-17),

5. 8337883 - Transdermal delivery systems (2012-12-25),

6. 7163688 - Osmotic implant with membrane and membrane retention means (2007-01-16),

7. 6835194 - Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners (2004-12-28),

8. 6638263 - Regulation of drug delivery through flow diversion (2003-10-28),

9. 6217906 - Self adjustable exit port (2001-04-17),

10. 6071305 - Directional drug delivery stent and method of use (2000-06-06),

11. 5997527 - Self adjustable exit port (1999-12-07),

12. 5972369 - Diffusional implantable delivery system (1999-10-26),

Title: The Visionary Inventor: James E Brown and his Innovations in Preventing Organ Dysfunction

Introduction:

James E Brown, a visionary inventor hailing from Los Gatos, CA, has made significant contributions to the field of innovation with a total of 12 patents to his name. His relentless drive to make a difference and his innovative spirit have solidified his reputation as a forward-thinker in the world of invention.

Latest Patents:

Among his latest patents is the groundbreaking "Uses of oxygenated cholesterol sulfates (OCS)" method. This innovative approach focuses on preventing and/or treating ischemia, organ dysfunction, and organ failure, including conditions like multiple organ dysfunction syndrome (MODS) and necrosis. The method involves utilizing oxygenated cholesterol sulfates, such as 5-cholesten-3,25-diol, 3-sulfate (25H-C3S), to treat organs both in vivo and ex vivo settings.

Career Highlights:

Having worked at notable companies like Durect Corporation and Alza Corporation, James E Brown has honed his innovative skills and brought his transformative ideas to life. His expertise and dedication to advancing medical treatments have been instrumental in shaping the future of healthcare technologies.

Collaborations:

Throughout his career, James E Brown has collaborated with esteemed professionals such as Felix T Theeuwes and Keith E Dionne. These collaborations have not only led to the successful implementation of his inventions but have also fostered a culture of innovation and creativity within the organizations he has been a part of.

Conclusion:

In conclusion, James E Brown's innovative approach to addressing organ dysfunction through the application of oxygenated cholesterol sulfates showcases his revolutionary thinking and commitment to improving healthcare outcomes. His contributions continue to inspire and pave the way for a more advanced and promising future in the field of medical innovation.

This text is generated by artificial intelligence and may not be accurate.